Quidel | QDEL - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Abbott USD 6.8B 1.72B 2026-03
Agilent USD 1.81B 49M 2026-03
Becton, Dickinson and Co. USD 708M 105M 2026-06
Bruker USD 184.9M 51.5M 2026-06
Cerus USD 19.96M 4.29M 2025-12
Charles River Laboratories USD 192.02M 195K 2026-06
Danaher USD 4.35B 1.35B 2026-06
Haemonetics USD 223.38M 22.06M 2026-06
Illumina USD 1.09B 329M 2026-03
IQVIA Holdings USD 1.91B 38M 2026-06
Merit Medical Systems USD 448.7M 39.38M 2026-06
Mettler Toledo International USD 51.38M 9.19M 2026-06
Myriad Genetics USD 115.2M 9.2M 2026-06
Neogen USD 159.9M 14.56M 2025-12
OraSure Technologies USD 160.58M 16.38M 2026-06
Pacific Biosciences Of California USD 61M 4.73M 2026-06
Quidel USD 123.4M 17M 2026-06
Revvity USD 1.02B 162.62M 2026-06
STAAR Surgical USD 153.15M 23M 2025-12
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Waters USD 539M 77M 2026-06